Shilpa Medicare Ltd.

View in App
544.05 +13.15 ▲2.5%

26 April 2024, 04:02:39 PM
Volume: 374,684

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.vbshilpa.com
Market Cap 5,334.49 Cr.
Enterprise Value(EV) 6,174.01 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -0.07 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-12
Industry PE 41.99 Trailing Twelve Months Ending 2023-12
Book Value / Share 234.10 Trailing Twelve Months Ending 2023-12
Price to Book Value 2.33 Calculated using Price: 545.50
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 9.78 Cr. 97,790,908 Shares
FaceValue 1
About Shilpa Medicare Ltd.
Shilpa Medicare, established in 1987, has carved a niche for itself in the exceedingly competitive and quality-conscious sphere of pharmaceuticals manufacturing. It produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.

Shilpa Medicare Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Shilpa Medicare Ltd. Performance

View details >>
1 Day
+2.48%
1 Week
+3.74%
1 Month
+20.85%
3 Month
+64.49%
6 Month
+76.24%
1 Year
+113.56%
2 Year
+17.99%
5 Year
+36.90%
10 Year
+146.57%

Shilpa Medicare Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 15.4 17.66 12.85 9.93 9.59 12.23 10.41 3.67 -1.71
Return on Capital Employed (%) 17.9 19.69 15.28 11.13 10.45 12.38 10.73 5.94 0.8
Return on Assets (%) 9.18 11.41 8.69 6.92 7.04 8.59 6.33 2.2 -1.07

Shilpa Medicare Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 547 639 987 1,085 1,198 1,329 1,479 1,822 1,783 1,783
Non Curr. Liab. 154 67 251 153 167 257 561 453 345 599
Curr. Liab. 189 222 237 266 253 411 587 612 783 630
Minority Int. 14 2 -3 -5 -8 -8 -11 -11 -9 -9
Equity & Liab. 905 931 1,472 1,499 1,610 1,989 2,632 2,876 2,902 3,004
Non Curr. Assets 577 577 742 827 1,065 1,365 1,730 1,988 2,134 2,179
Curr. Assets 328 354 730 672 545 624 862 887 768 825
Misc. Exp. not W/O 0
Total Assets 905 931 1,472 1,499 1,610 1,989 2,632 2,876 2,902 3,004

Shilpa Medicare Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 614 716 779 789 733 908 901 1,146 1,050 1,123
Other Income 7 11 29 33 16 22 40 21 31 8
Total Income 621 728 809 821 749 930 941 1,166 1,082 1,131
Total Expenditure -487 -556 -618 -638 -579 -693 -729 -948 -962 -911
PBIDT 133 171 191 184 170 237 212 218 120 221
Interest -4 -4 -3 -3 -4 -5 -22 -41 -59 -85
Depreciation -21 -23 -31 -37 -42 -44 -54 -80 -96 -107
Taxation -35 -36 -42 -34 -26 -33 -49 -42 7 -23
Exceptional Items 0 -2 -5 20 61 9
PAT 73 105 104 103 110 155 146 61 -31 5
Minority Interest 1 4 3 2 3 2 2 0 -2 0
Share Associate -6
Other Related Items
Consolidated Net Profit 74 108 108 105 112 156 148 61 -32 -1
Adjusted EPS 10 14 13 13 14 19 18 7 -4 0

Shilpa Medicare Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 70 69 129 37 45 147 124 47 105 226
Cash Fr. Inv. -49 -195 -109 -262 -9 -196 -290 -404 -286 -278
Cash Fr. Finan. -28 136 -20 313 -61 10 176 436 83 46
Net Change -7 10 0 88 -25 -39 10 79 -98 -7
Cash & Cash Eqvt 9 18 6 100 74 34 44 123 25 19

Shilpa Medicare Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 50.01 50.01 50.01 50.01 50.01 50.01 50.01 50.01 50.01
Public 49.99 49.99 49.99 49.99 49.99 49.99 49.99 49.99 49.99
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.81 0.81 0.81 1.38 12.90 12.90 90.41 90.41 90.41
No. of Shareholders (in Lacs)

Shilpa Medicare Ltd. Announcements

View details >>
Thu, 18 Apr 2024
Updates
Shilpa Medicare Limited has informed the Exchange regarding 'Launch of Pemetrexed Injection,'.
Tue, 16 Apr 2024
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Shilpa Medicare Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Tue, 16 Apr 2024
Updates
Shilpa Medicare Limited has informed the Exchange regarding ''Europe GMP Approval of Shilpa Medicare Ltd. Unit 4, Jadcherla, Telangana.

Shilpa Medicare Ltd. Technical Scans

View details >>
Fri, 26 Apr 2024
Closing Above Previous High Closing Above Previous High
Close Within 52 Week High Zone Close Within 52 Week High Zone
Making Lower Lows for 2 Days Making Lower Lows for 2 Days
High Increase in 1 Month High Increase in 1 Month
High Increase in 3 Months High Increase in 3 Months

Shilpa Medicare Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 360,919.96 1,506.55 -0.9%
Cipla Ltd. 113,794.25 1,409.15 +0.2%
Divi's Laboratories Ltd. 106,860.39 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. 104,315.63 6,252.10 +0.5%
Zydus Lifesciences Ltd. 95,380.92 947.40 -0.4%
Mankind Pharma Ltd. 94,869.36 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. 91,057.05 2,691.00 -0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.52 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-12 30.69 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-12 77.27 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.95 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.07 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-12 54.93 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 60.95 2,691.00 -0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.78 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-12 4.39 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-12 8.20 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.88 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.06 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-12 10.68 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.73 2,691.00 -0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 0.02 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,691.00 -0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,691.00 -0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,691.00 -0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,691.00 -0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,506.55 -0.9%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,409.15 +0.2%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 4,016.35 +4.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,252.10 +0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 947.40 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,369.00 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,691.00 -0.1%

Shilpa Medicare Ltd. FAQ's

What is Shilpa Medicare share price?
Can I buy Shilpa Medicare shares now?
What is the Market Cap of Shilpa Medicare?
What are the key metrics to analyse Shilpa Medicare?
What is the 52 Week High and Low of Shilpa Medicare?
What is the trend of Shilpa Medicare share price?